Obesity is associated with worsened outcomes in patients with ulcerative colitis on advanced therapies: A propensity matched cohort study from the U.S
"What it's doing is taking advantage of a specific section of the law that gives the federal government the ability to stand up a temporary program." The program marks the first time Medicare will help pay for drugs prescribed solely for obesity, rather than limiting coverage to people taking GLP-1s for conditions such as diabetes or cardiovascular disease
However, studies using beta-3-adrenergic receptor knockout mice revealed a more complex picture: Long-term AOD-9604 treatment failed to produce weight loss in beta-3-AR knockout mice Acute administration still increased energy expenditure and fat oxidation in knockout mice This suggests beta-3-AR expression enhancement contributes to, but does not directly mediate, lipolytic effects The peptide appears to work through an unidentified receptor mechanism that subsequently influences beta-3-adrenergic signaling pathways
Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer
In rodent models, these cellular changes result in reduced steatosis, lobular inflammation, and ballooning
